Published mark
NEUROONE MEDICAL TECHNOLOGIES Corp
NASDAQ: NMTC. Canonical company identity and public leadership record.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e
- SEC CIK
- 0001500198
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 7, 2026
- Newest evidence
- Mar 9, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- David RosaSince Mar 9, 2026
- Chair
- Not published
- Independent
- 4 / 55 directors published
- Published claims
- 262 distinct sources
- Evidence records
- 80 pinned
- Source conflicts
- 0None open
Built from 2 distinct sources and 8 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
EXECUTIVE APPOINTED
Christopher Volker executive of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2026-03-09.
EffectiveEffective Mar 9, 2026E3
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Chief Operating Officer | Christopher Volker | Mar 2026 | current | Source reportedE3 |
| Chief Executive Officer, President and Director | David Rosa | Mar 2026 | current | Source reportedE4 |
| Chief Administrative Officer, General Counsel | Emily Johns | Mar 2026 | current | Source reportedE5 |
| Chief Financial Officer | Ronald McClurg | Mar 2026 | current | Source reportedE6 |
| Chief Technology Officer | Steve Mertens | Mar 2026 | current | Source reportedE7 |
Board of directors
Evidence5 directors published. 4 of 5 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| David Rosa | Not independent | 2017 | None published | Source reportedE2 |
| Edward Andrle | Independent | 2020 | AuditAudit; Nominating and Governance · ChairNominating and Governance, chair | Source reportedE2 |
| Jason Mills | Independent | 2025 | CompensationCompensation; Nominating and GovernanceNominating and Governance | Source reportedE2 |
| Jeffrey S. Mathiesen | Independent | 2017 | Audit, chairAudit · Chair; Compensation; Nominating and GovernanceCompensationNominating and Governance | Source reportedE2 |
| Paul Buckman | Independent | 2017 | AuditAudit; Compensation · ChairCompensation, chair | Source reportedE2 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Jeffrey S. Mathiesen | Jeffrey S. Mathiesen, Edward Andrle, Paul Buckman, Jeffrey S. Mathiesen, Edward Andrle, Paul Buckman | Not described in the published record |
| Audit · Chair; Compensation; Nominating and Governance | Not published | Jeffrey S. Mathiesen | Not described in the published record |
| Audit; Compensation · Chair | Not published | Paul Buckman | Not described in the published record |
| Audit; Nominating and Governance · Chair | Not published | Edward Andrle | Not described in the published record |
| Compensation | Paul Buckman | Paul Buckman, Jason Mills, Jeffrey S. Mathiesen, Paul Buckman, Jason Mills, Jeffrey S. Mathiesen | Not described in the published record |
| Compensation; Nominating and Governance | Not published | Jason Mills | Not described in the published record |
| Nominating and Governance | Edward Andrle | Edward Andrle, Jason Mills, Jeffrey S. Mathiesen, Edward Andrle, Jason Mills, Jeffrey S. Mathiesen | Not described in the published record |
Committee RecordAudit: Chair Jeffrey S. Mathiesen; Members Jeffrey S. Mathiesen (Chair); Edward Andrle; Paul Buckman
Committee AppointmentJeffrey S. Mathiesen: chair, Audit
Committee AppointmentEdward Andrle: member, Audit
Committee AppointmentPaul Buckman: member, Audit
Committee RecordCompensation: Chair Paul Buckman; Members Paul Buckman (Chair); Jason Mills; Jeffrey S. Mathiesen
Committee AppointmentPaul Buckman: chair, Compensation
Committee AppointmentJason Mills: member, Compensation
Committee AppointmentJeffrey S. Mathiesen: member, Compensation
Committee RecordNominating and Governance: Chair Edward Andrle; Members Edward Andrle (Chair); Jason Mills; Jeffrey S. Mathiesen
Committee AppointmentEdward Andrle: chair, Nominating and Governance
Committee AppointmentJason Mills: member, Nominating and Governance
Committee AppointmentJeffrey S. Mathiesen: member, Nominating and Governance
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerDavid Rosa, Chief Executive Officer, President and Director, from Mar 9, 2026
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceSecurity ListingNMTC (NASDAQ)
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 7, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameNEUROONE MEDICAL TECHNOLOGIES Corp
Entity StatusPublic listing published
Published FactUS
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Christopher VolkerChief Operating Officercompany:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:10
- David RosaChief Executive Officer, President and Directorcompany:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:11, company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:5
- Emily JohnsChief Administrative Officer, General Counselcompany:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:12
- Ronald McClurgChief Financial Officercompany:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:13
- Steve MertensChief Technology Officercompany:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:14
- Edward AndrleDirectorcompany:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:6
- Jason MillsDirectorcompany:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:7
- Jeffrey S. MathiesenDirectorcompany:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:8
- Paul BuckmanDirectorcompany:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:9
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 8 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 7, 2026. Cited by 4 Claims.
- E2sec proxy. Published Mar 9, 2026. Retrieved Apr 25, 2026. Cited by 5 Claims.
- E3sec filing. Published Mar 9, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E4sec filing. Published Mar 9, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E5sec filing. Published Mar 9, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E6sec filing. Published Mar 9, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E7sec filing. Published Mar 9, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E8board_seats. board seats. Cited by 12 Claims.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 7, 2026- Christopher Volker executive of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2026-03-09.
- David Rosa executive of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2026-03-09.
- Emily Johns executive of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2026-03-09.
- Ronald McClurg executive of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2026-03-09.
- Steve Mertens executive of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2026-03-09.
- Jason Mills seat on NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2025-01-01.
- Compensation; Nominating and Governance committee of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2025-01-01.
- Jason Mills member of Compensation; Nominating and Governance, effective 2025-01-01.
- Edward Andrle seat on NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2020-01-01.
- Audit; Nominating and Governance · Chair committee of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2020-01-01.
- Edward Andrle member of Audit; Nominating and Governance · Chair, effective 2020-01-01.
- David Rosa seat on NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2017-01-01.
- Jeffrey S. Mathiesen seat on NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2017-01-01.
- Paul Buckman seat on NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2017-01-01.
- Audit · Chair; Compensation; Nominating and Governance committee of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2017-01-01.
- Jeffrey S. Mathiesen member of Audit · Chair; Compensation; Nominating and Governance, effective 2017-01-01.
- Audit; Compensation · Chair committee of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2017-01-01.
- Paul Buckman member of Audit; Compensation · Chair, effective 2017-01-01.